XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Condensed Consolidating Financial Information | 3 Months Ended
--- | ---
Mar. 31, 2018
Condensed Financial Information of Parent Company Only Disclosure [Abstract] |
Condensed Consolidating Financial Information | Condensed Consolidating Financial Information The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X, Rule 3-10, “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.” Each of the subsidiary guarantors is 100% owned by Encompass Health, and all guarantees are full and unconditional and joint and several, subject to certain customary conditions for release. Encompass Health’s investments in its consolidated subsidiaries, as well as guarantor subsidiaries’ investments in nonguarantor subsidiaries and nonguarantor subsidiaries’ investments in guarantor subsidiaries, are presented under the equity method of accounting with the related investment presented within the line items Intercompany receivable and investments in consolidated affiliates and Intercompany payable in the accompanying condensed consolidating balance sheets. The terms of our credit agreement allow us to declare and pay cash dividends on our common stock so long as: (1) we are not in default under our credit agreement and (2) our senior secured leverage ratio (as defined in our credit agreement) remains less than or equal to 2x. The terms of our senior note indenture allow us to declare and pay cash dividends on our common stock so long as (1) we are not in default, (2) the consolidated coverage ratio (as defined in the indenture) exceeds 2x or we are otherwise allowed under the indenture to incur debt, and (3) we have capacity under the indenture’s restricted payments covenant to declare and pay dividends. See Note 9, Long-term Debt, to the consolidated financial statements accompanying the 2017 Form 10-K. Periodically, certain wholly owned subsidiaries of Encompass Health make dividends or distributions of available cash and/or intercompany receivable balances to their parents. In addition, Encompass Health makes contributions to certain wholly owned subsidiaries. When made, these dividends, distributions, and contributions impact the Intercompany receivable and investments in consolidated affiliates, Intercompany payable, and Encompass Health shareholders’ equity line items in the accompanying condensed consolidating balance sheet but have no impact on the consolidated financial statements of Encompass Health Corporation.
| Three Months Ended March 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.4 |  |  | $ | 587.0 |  |  | $ | 486.2 |  |  | $ | (32.6 | ) |  | $ | 1,046.0 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 13.2 |  |  | 279.2 |  |  | 283.2 |  |  | (5.4 | ) |  | 570.2 |
Other operating expenses | 8.4 |  |  | 83.7 |  |  | 61.5 |  |  | (12.4 | ) |  | 141.2 |
Occupancy costs | 0.5 |  |  | 23.7 |  |  | 9.2 |  |  | (14.8 | ) |  | 18.6 |
Supplies | — |  |  | 24.4 |  |  | 15.5 |  |  | — |  |  | 39.9 |
General and administrative expenses | 39.4 |  |  | — |  |  | 21.7 |  |  | — |  |  | 61.1 |
Depreciation and amortization | 2.0 |  |  | 26.1 |  |  | 17.8 |  |  | — |  |  | 45.9 |
Total operating expenses | 63.5 |  |  | 437.1 |  |  | 408.9 |  |  | (32.6 | ) |  | 876.9 |
Interest expense and amortization of debt discounts and fees | 29.8 |  |  | 5.2 |  |  | 5.7 |  |  | (5.1 | ) |  | 35.6 |
Other (income) loss | (4.7 | ) |  | (0.2 | ) |  | (0.1 | ) |  | 5.1 |  |  | 0.1 |
Equity in net income of nonconsolidated affiliates | — |  |  | (1.9 | ) |  | (0.4 | ) |  | — |  |  | (2.3 | )
Equity in net income of consolidated affiliates | (112.0 | ) |  | (17.8 | ) |  | — |  |  | 129.8 |  |  | — |
Management fees | (38.4 | ) |  | 28.4 |  |  | 10.0 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 67.2 |  |  | 136.2 |  |  | 62.1 |  |  | (129.8 | ) |  | 135.7 |
Provision for income tax (benefit) expense | (17.1 | ) |  | 36.7 |  |  | 10.4 |  |  | — |  |  | 30.0 |
Income from continuing operations | 84.3 |  |  | 99.5 |  |  | 51.7 |  |  | (129.8 | ) |  | 105.7 |
Loss from discontinued operations, net of tax | (0.5 | ) |  | — |  |  | — |  |  | — |  |  | (0.5 | )
Net income | 83.8 |  |  | 99.5 |  |  | 51.7 |  |  | (129.8 | ) |  | 105.2 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (21.4 | ) |  | — |  |  | (21.4 | )
Net income attributable to Encompass Health | $ | 83.8 |  |  | $ | 99.5 |  |  | $ | 30.3 |  |  | $ | (129.8 | ) |  | $ | 83.8 |
Comprehensive income | $ | 83.8 |  |  | $ | 99.5 |  |  | $ | 51.7 |  |  | $ | (129.8 | ) |  | $ | 105.2 |
Comprehensive income attributable to Encompass Health | $ | 83.8 |  |  | $ | 99.5 |  |  | $ | 30.3 |  |  | $ | (129.8 | ) |  | $ | 83.8 |
| Three Months Ended March 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net operating revenues | $ | 5.3 |  |  | $ | 560.7 |  |  | $ | 422.3 |  |  | $ | (31.2 | ) |  | $ | 957.1 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |
Salaries and benefits | 11.2 |  |  | 270.3 |  |  | 253.9 |  |  | (5.3 | ) |  | 530.1 |
Other operating expenses | 8.2 |  |  | 76.9 |  |  | 54.6 |  |  | (11.9 | ) |  | 127.8 |
Occupancy costs | 0.5 |  |  | 23.3 |  |  | 8.1 |  |  | (14.0 | ) |  | 17.9 |
Supplies | — |  |  | 23.5 |  |  | 13.5 |  |  | — |  |  | 37.0 |
General and administrative expenses | 31.6 |  |  | — |  |  | 4.9 |  |  | — |  |  | 36.5 |
Depreciation and amortization | 2.4 |  |  | 25.7 |  |  | 17.1 |  |  | — |  |  | 45.2 |
Total operating expenses | 53.9 |  |  | 419.7 |  |  | 352.1 |  |  | (31.2 | ) |  | 794.5 |
Interest expense and amortization of debt discounts and fees | 35.2 |  |  | 5.4 |  |  | 5.8 |  |  | (5.1 | ) |  | 41.3 |
Other income | (5.4 | ) |  | (0.1 | ) |  | (0.6 | ) |  | 5.1 |  |  | (1.0 | )
Equity in net income of nonconsolidated affiliates | — |  |  | (1.9 | ) |  | (0.2 | ) |  | — |  |  | (2.1 | )
Equity in net income of consolidated affiliates | (86.2 | ) |  | (9.8 | ) |  | — |  |  | 96.0 |  |  | — |
Management fees | (35.9 | ) |  | 27.1 |  |  | 8.8 |  |  | — |  |  | — |
Income from continuing operations before income tax (benefit) expense | 43.7 |  |  | 120.3 |  |  | 56.4 |  |  | (96.0 | ) |  | 124.4 |
Provision for income tax (benefit) expense | (23.4 | ) |  | 48.0 |  |  | 15.1 |  |  | — |  |  | 39.7 |
Income from continuing operations | 67.1 |  |  | 72.3 |  |  | 41.3 |  |  | (96.0 | ) |  | 84.7 |
Loss from discontinued operations, net of tax | (0.3 | ) |  | — |  |  | — |  |  | — |  |  | (0.3 | )
Net income | 66.8 |  |  | 72.3 |  |  | 41.3 |  |  | (96.0 | ) |  | 84.4 |
Less: Net income attributable to noncontrolling interests | — |  |  | — |  |  | (17.6 | ) |  | — |  |  | (17.6 | )
Net income attributable to Encompass Health | $ | 66.8 |  |  | $ | 72.3 |  |  | $ | 23.7 |  |  | $ | (96.0 | ) |  | $ | 66.8 |
Comprehensive income | $ | 67.1 |  |  | $ | 72.3 |  |  | $ | 41.3 |  |  | $ | (96.0 | ) |  | $ | 84.7 |
Comprehensive income attributable to Encompass Health | $ | 67.1 |  |  | $ | 72.3 |  |  | $ | 23.7 |  |  | $ | (96.0 | ) |  | $ | 67.1 |
| As of March 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 14.6 |  |  | $ | — |  |  | $ | 86.4 |
Restricted cash | — |  |  | — |  |  | 69.4 |  |  | — |  |  | 69.4 |
Accounts receivable | — |  |  | 276.9 |  |  | 186.2 |  |  | — |  |  | 463.1 |
Other current assets | 81.7 |  |  | 19.5 |  |  | 75.5 |  |  | (87.1 | ) |  | 89.6 |
Total current assets | 150.7 |  |  | 299.2 |  |  | 345.7 |  |  | (87.1 | ) |  | 708.5 |
Property and equipment, net | 119.0 |  |  | 1,003.5 |  |  | 431.8 |  |  | — |  |  | 1,554.3 |
Goodwill | — |  |  | 854.6 |  |  | 1,118.5 |  |  | — |  |  | 1,973.1 |
Intangible assets, net | 11.7 |  |  | 103.8 |  |  | 280.6 |  |  | — |  |  | 396.1 |
Deferred income tax assets | 96.9 |  |  | 8.4 |  |  | 5.4 |  |  | (42.2 | ) |  | 68.5 |
Other long-term assets | 49.6 |  |  | 97.6 |  |  | 91.9 |  |  | — |  |  | 239.1 |
Intercompany notes receivable | 463.6 |  |  | — |  |  | — |  |  | (463.6 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,860.0 |  |  | 413.5 |  |  | — |  |  | (3,273.5 | ) |  | — |
Total assets | $ | 3,751.5 |  |  | $ | 2,780.6 |  |  | $ | 2,273.9 |  |  | $ | (3,866.4 | ) |  | $ | 4,939.6 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 32.8 |  |  | $ | 7.6 |  |  | $ | 9.8 |  |  | $ | (17.5 | ) |  | $ | 32.7 |
Accounts payable | 12.2 |  |  | 44.2 |  |  | 26.7 |  |  | — |  |  | 83.1 |
Accrued expenses and other current liabilities | 217.4 |  |  | 73.4 |  |  | 235.0 |  |  | (69.6 | ) |  | 456.2 |
Total current liabilities | 262.4 |  |  | 125.2 |  |  | 271.5 |  |  | (87.1 | ) |  | 572.0 |
Long-term debt, net of current portion | 2,261.7 |  |  | 240.2 |  |  | 42.5 |  |  | — |  |  | 2,544.4 |
Intercompany notes payable | — |  |  | — |  |  | 463.6 |  |  | (463.6 | ) |  | — |
Other long-term liabilities | 30.4 |  |  | 17.6 |  |  | 178.3 |  |  | (42.5 | ) |  | 183.8 |
Intercompany payable | — |  |  | — |  |  | 99.4 |  |  | (99.4 | ) |  | — |
| 2,554.5 |  |  | 383.0 |  |  | 1,055.3 |  |  | (692.6 | ) |  | 3,300.2 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 198.6 |  |  | — |  |  | 198.6 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,197.0 |  |  | 2,397.6 |  |  | 776.2 |  |  | (3,173.8 | ) |  | 1,197.0 |
Noncontrolling interests | — |  |  | — |  |  | 243.8 |  |  | — |  |  | 243.8 |
Total shareholders’ equity | 1,197.0 |  |  | 2,397.6 |  |  | 1,020.0 |  |  | (3,173.8 | ) |  | 1,440.8 |
Total liabilities and shareholders’ equity | $ | 3,751.5 |  |  | $ | 2,780.6 |  |  | $ | 2,273.9 |  |  | $ | (3,866.4 | ) |  | $ | 4,939.6 |
| As of December 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Assets |  |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash | — |  |  | — |  |  | 62.4 |  |  | — |  |  | 62.4 |
Accounts receivable | — |  |  | 285.2 |  |  | 186.9 |  |  | — |  |  | 472.1 |
Other current assets | 61.4 |  |  | 21.7 |  |  | 48.7 |  |  | (18.5 | ) |  | 113.3 |
Total current assets | 95.7 |  |  | 309.8 |  |  | 315.2 |  |  | (18.5 | ) |  | 702.2 |
Property and equipment, net | 101.8 |  |  | 991.5 |  |  | 423.8 |  |  | — |  |  | 1,517.1 |
Goodwill | — |  |  | 854.6 |  |  | 1,118.0 |  |  | — |  |  | 1,972.6 |
Intangible assets, net | 11.8 |  |  | 105.1 |  |  | 286.2 |  |  | — |  |  | 403.1 |
Deferred income tax assets | 97.4 |  |  | 8.4 |  |  | — |  |  | (42.2 | ) |  | 63.6 |
Other long-term assets | 49.2 |  |  | 100.5 |  |  | 85.4 |  |  | — |  |  | 235.1 |
Intercompany notes receivable | 486.2 |  |  | — |  |  | — |  |  | (486.2 | ) |  | — |
Intercompany receivable and investments in consolidated affiliates | 2,839.1 |  |  | 311.3 |  |  | — |  |  | (3,150.4 | ) |  | — |
Total assets | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
Liabilities and Shareholders’ Equity |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | 32.8 |  |  | $ | 7.4 |  |  | $ | 9.6 |  |  | $ | (17.5 | ) |  | $ | 32.3 |
Accounts payable | 10.4 |  |  | 43.5 |  |  | 24.5 |  |  | — |  |  | 78.4 |
Accrued expenses and other current liabilities | 166.8 |  |  | 82.0 |  |  | 159.0 |  |  | (1.0 | ) |  | 406.8 |
Total current liabilities | 210.0 |  |  | 132.9 |  |  | 193.1 |  |  | (18.5 | ) |  | 517.5 |
Long-term debt, net of current portion | 2,258.5 |  |  | 242.2 |  |  | 44.7 |  |  | — |  |  | 2,545.4 |
Intercompany notes payable | — |  |  | — |  |  | 486.2 |  |  | (486.2 | ) |  | — |
Other long-term liabilities | 31.0 |  |  | 17.8 |  |  | 178.6 |  |  | (42.1 | ) |  | 185.3 |
Intercompany payable | — |  |  | — |  |  | 144.8 |  |  | (144.8 | ) |  | — |
| 2,499.5 |  |  | 392.9 |  |  | 1,047.4 |  |  | (691.6 | ) |  | 3,248.2 |
Commitments and contingencies |  |  |  |  |  |  |  |  |  |  |  |  |  |
Redeemable noncontrolling interests | — |  |  | — |  |  | 220.9 |  |  | — |  |  | 220.9 |
Shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Encompass Health shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 717.4 |  |  | (3,005.7 | ) |  | 1,181.7 |
Noncontrolling interests | — |  |  | — |  |  | 242.9 |  |  | — |  |  | 242.9 |
Total shareholders’ equity | 1,181.7 |  |  | 2,288.3 |  |  | 960.3 |  |  | (3,005.7 | ) |  | 1,424.6 |
Total liabilities and shareholders’ equity | $ | 3,681.2 |  |  | $ | 2,681.2 |  |  | $ | 2,228.6 |  |  | $ | (3,697.3 | ) |  | $ | 4,893.7 |
| Three Months Ended March 31, 2018
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 10.5 |  |  | $ | 112.3 |  |  | $ | 93.5 |  |  | $ | — |  |  | $ | 216.3 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (12.3 | ) |  | (31.4 | ) |  | (16.2 | ) |  | — |  |  | (59.9 | )
Acquisitions of businesses, net of cash acquired | — |  |  | — |  |  | (0.6 | ) |  | — |  |  | (0.6 | )
Proceeds from repayment of intercompany note receivable | 22.0 |  |  | — |  |  | — |  |  | (22.0 | ) |  | — |
Other, net | (5.1 | ) |  | (0.1 | ) |  | 5.1 |  |  | — |  |  | (0.1 | )
Net cash provided by (used in) investing activities | 4.6 |  |  | (31.5 | ) |  | (11.7 | ) |  | (22.0 | ) |  | (60.6 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on intercompany note payable | — |  |  | — |  |  | (22.0 | ) |  | 22.0 |  |  | — |
Borrowings on revolving credit facility | 95.0 |  |  | — |  |  | — |  |  | — |  |  | 95.0 |
Payments on revolving credit facility | (95.0 | ) |  | — |  |  | — |  |  | — |  |  | (95.0 | )
Dividends paid on common stock | (25.3 | ) |  | — |  |  | (0.1 | ) |  | — |  |  | (25.4 | )
Purchase of equity interests in consolidated affiliates | (65.1 | ) |  | — |  |  | — |  |  | — |  |  | (65.1 | )
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (15.4 | ) |  | — |  |  | (15.4 | )
Other, net | (5.1 | ) |  | (1.8 | ) |  | (3.9 | ) |  | — |  |  | (10.8 | )
Change in intercompany advances | 115.1 |  |  | (79.1 | ) |  | (36.0 | ) |  | — |  |  | — |
Net cash provided by (used in) financing activities | 19.6 |  |  | (80.9 | ) |  | (77.4 | ) |  | 22.0 |  |  | (116.7 | )
Increase (decrease) in cash, cash equivalents, and restricted cash | 34.7 |  |  | (0.1 | ) |  | 4.4 |  |  | — |  |  | 39.0 |
Cash, cash equivalents, and restricted cash at beginning of period | 34.3 |  |  | 2.9 |  |  | 79.6 |  |  | — |  |  | 116.8 |
Cash, cash equivalents, and restricted cash at end of period | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 84.0 |  |  | $ | — |  |  | $ | 155.8 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 17.2 |  |  | $ | — |  |  | $ | 54.4 |
Restricted cash at beginning of period | — |  |  | — |  |  | 62.4 |  |  | — |  |  | 62.4 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 34.3 |  |  | $ | 2.9 |  |  | $ | 79.6 |  |  | $ | — |  |  | $ | 116.8 |
Cash and cash equivalents at end of period | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 14.6 |  |  | $ | — |  |  | $ | 86.4 |
Restricted cash at end of period | — |  |  | — |  |  | 69.4 |  |  | — |  |  | 69.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 69.0 |  |  | $ | 2.8 |  |  | $ | 84.0 |  |  | $ | — |  |  | $ | 155.8 |
| Three Months Ended March 31, 2017
| Encompass Health Corporation |  | Guarantor Subsidiaries |  | Nonguarantor Subsidiaries |  | Eliminating Entries |  | Encompass Health Consolidated
| (In Millions)
Net cash provided by operating activities | $ | 45.1 |  |  | $ | 72.1 |  |  | $ | 63.6 |  |  | $ | — |  |  | $ | 180.8 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchases of property and equipment | (5.2 | ) |  | (12.9 | ) |  | (23.1 | ) |  | — |  |  | (41.2 | )
Acquisitions of businesses, net of cash acquired | (10.9 | ) |  | — |  |  | (5.5 | ) |  | — |  |  | (16.4 | )
Proceeds from repayment of intercompany note receivable | 7.0 |  |  | — |  |  | — |  |  | (7.0 | ) |  | — |
Other, net | (3.8 | ) |  | 8.8 |  |  | 3.5 |  |  | — |  |  | 8.5 |
Net cash used in investing activities | (12.9 | ) |  | (4.1 | ) |  | (25.1 | ) |  | (7.0 | ) |  | (49.1 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Principal payments on intercompany note payable | — |  |  | — |  |  | (7.0 | ) |  | 7.0 |  |  | — |
Borrowings on revolving credit facility | 55.0 |  |  | — |  |  | — |  |  | — |  |  | 55.0 |
Payments on revolving credit facility | (122.0 | ) |  | — |  |  | — |  |  | — |  |  | (122.0 | )
Repurchases of common stock, including fees and expenses | (18.1 | ) |  | — |  |  | — |  |  | — |  |  | (18.1 | )
Dividends paid on common stock | (22.2 | ) |  | — |  |  | — |  |  | — |  |  | (22.2 | )
Proceeds from exercising stock warrants | 26.6 |  |  | — |  |  | — |  |  | — |  |  | 26.6 |
Distributions paid to noncontrolling interests of consolidated affiliates | — |  |  | — |  |  | (11.5 | ) |  | — |  |  | (11.5 | )
Other, net | (12.0 | ) |  | (1.6 | ) |  | (0.5 | ) |  | — |  |  | (14.1 | )
Change in intercompany advances | 82.3 |  |  | (65.4 | ) |  | (16.9 | ) |  | — |  |  | — |
Net cash used in financing activities | (10.4 | ) |  | (67.0 | ) |  | (35.9 | ) |  | 7.0 |  |  | (106.3 | )
Increase in cash, cash equivalents, and restricted cash | 21.8 |  |  | 1.0 |  |  | 2.6 |  |  | — |  |  | 25.4 |
Cash, cash equivalents, and restricted cash at beginning of period | 20.6 |  |  | 1.6 |  |  | 79.2 |  |  | — |  |  | 101.4 |
Cash, cash equivalents, and restricted cash at end of period | $ | 42.4 |  |  | $ | 2.6 |  |  | $ | 81.8 |  |  | $ | — |  |  | $ | 126.8 |
Reconciliation of Cash, Cash Equivalents, and Restricted Cash |  |  |  |  |  |  |  |  |
Cash and cash equivalents at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 18.3 |  |  | $ | — |  |  | $ | 40.5 |
Restricted cash at beginning of period | — |  |  | — |  |  | 60.9 |  |  | — |  |  | 60.9 |
Cash, cash equivalents, and restricted cash at beginning of period | $ | 20.6 |  |  | $ | 1.6 |  |  | $ | 79.2 |  |  | $ | — |  |  | $ | 101.4 |
Cash and cash equivalents at end of period | $ | 42.4 |  |  | $ | 2.6 |  |  | $ | 16.2 |  |  | $ | — |  |  | $ | 61.2 |
Restricted cash at end of period | — |  |  | — |  |  | 65.6 |  |  | — |  |  | 65.6 |
Cash, cash equivalents, and restricted cash at end of period | $ | 42.4 |  |  | $ | 2.6 |  |  | $ | 81.8 |  |  | $ | — |  |  | $ | 126.8 |

X
- References No definition available. + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.7-05(c)(Schedule II)) -URI http://asc.fasb.org/extlink&oid=6879921&loc=d3e569147-122900 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=96868048&loc=d3e5283-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 2 -Subparagraph (SX 210.9-06) -URI http://asc.fasb.org/extlink&oid=6882215&loc=d3e537971-122884 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 10 -Section S99 -Paragraph 6 -Subparagraph (SX 210.5-04(c)(Schedule I)) -URI http://asc.fasb.org/extlink&oid=27047687&loc=d3e5864-122674 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration